Centers for Disease Control and Prevention, Division of Reproductive Health Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2012
NCT01125696
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now